TEL AVIV, Israel, October 28, 2015 /PRNewswire/ --
Elbit Imaging Ltd. ("EI" or
the "Company") (TASE, NASDAQ:
EMITF) announced today that following the Company's board of
directors' approval of a program to repurchase up to NIS fifty (50) million (approximately
$13 million) of Elbit's Series H
Notes and Series I Notes, the Company's board of directors
clarified that until further notice, the Company will purchase only
Series H Notes.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of
business: (i) Commercial centers - initiation, construction, and
sale of commercial centers and other mixed-use property projects,
predominantly in the retail sector, located in Central and
Eastern Europe. In certain
circumstances and depending on market conditions, the Group
operates and manages commercial centers prior to their sale. (ii)
Hotels - hotels operation and management. (iii) Medical industries
and devices - (a) research and development, production and
marketing of magnetic resonance imaging guided focused ultrasound
treatment equipment, and (b) development of stem cell population
expansion technologies and stem cell therapy products for
transplantation and regenerative medicine. (iv) Residential
projects - initiation, construction and sale of residential units
or plots designated for residential located primarily in
India.
Any forward-looking statements in our releases include
statements regarding the intent, belief or current expectations of
Elbit Imaging Ltd. and our management about our business, financial
condition, results of operations, and its relationship with its
employees and the condition of our properties. Words such as
"believe," "expect,"
"intend," "estimate"
and similar expressions are intended to identify forward-looking
statements but are not the exclusive means of identifying such
statements. Actual results may differ materially from those
projected, expressed or implied in the forward-looking statements
as a result of various factors including, without limitation,
a change in market conditions, a decision to deploy the cash for
other business opportunities and the factors set forth in
our filings with the Securities and Exchange Commission including,
without limitation, Item 3.D of our annual report on Form 20-F for
the fiscal year ended December 31, 2014, under the
caption "Risk Factors." Any
forward-looking statements contained in our releases speak only as
of the date of such release, and we caution existing and
prospective investors not to place undue reliance on such
statements. Such forward-looking statements do not purport to be
predictions of future events or circumstances, and therefore, there
can be no assurance that any forward-looking statement contained
our releases will prove to be accurate. We undertake no obligation
to update or revise any forward-looking statements.
For Further Information
Company Contact
Ron Hadassi
Chairman of the Board of Directors
Tel: +972-3-608-6048
Fax: +972-3-608-6050
ron@elbitimaging.com
SOURCE Elbit Imaging Ltd.